Medpace Holdings, Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

432.28

+2.18 (0.51%)

May 22, 2026, 3:52 PM EDT - Market open

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Oncology Revenue	778.35M	747.59M	651.24M
Oncology Revenue Growth	4.12%	14.79%	10.93%
Metabolic Revenue	834.50M	744.96M	457.54M
Metabolic Revenue Growth	12.02%	62.82%	21.41%
Other Sources of Revenue	406.03M	408.55M	431.38M
Other Sources of Revenue Growth	-0.62%	-5.29%	6.56%
Cardiology Revenue	237.35M	239.37M	230.45M
Cardiology Revenue Growth	-0.84%	3.87%	18.98%
Central Nervous System Revenue	280.14M	254.84M	181.98M
Central Nervous System Revenue Growth	9.93%	40.04%	13.69%
AVAI Revenue	141.89M	134.94M	156.46M
AVAI Revenue Growth	5.16%	-13.76%	-4.20%
Revenue (Other)	2.00K	-4.00K	-4.00K
Revenue (Total)	2.68B	2.53B	2.11B
Revenue (Total) Growth	5.85%	19.97%	11.84%

Key Performance Indicators

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Net New Business Awards	2.77B	2.65B	2.23B
Net New Business Awards Growth	4.47%	18.69%	-5.38%
Total Backlog	2.93B	3.03B	2.90B
Total Backlog Growth	-3.24%	4.31%	3.17%
Book-to-Bill Ratio	-	1.05	1.06
Book-to-Bill Ratio Growth	-	-0.94%	-15.20%

Updated Apr 23, 2026. Data Source: Fiscal.ai.